The TRPV1 antagonist SB366791 appeared to prevent increased sensitivity to aconitine caused by low wDE based on VPB and VT, but aconitine doses required to elicit VF and cardiac arrest after wDE were comparable to those in rats without pretreatment (Figure 2C). This evidence concerns the gene TRPV1 and cardiac arrest.